Financials
| Div Yield |
3.1% |
7.8% |
| Div Cover |
2.54 |
n/a |
| Op Mrgn |
70.0% |
n/a |
| ROCE |
69.0% |
|
| P/E |
62.99 |
16.50 |
| PEG |
2.93 |
2.81 |
| Pr/Revenue |
11.17 |
n/a |
| Pr/Book |
3.96 |
|
| Revenue |
6.1% |
n/a |
| PBT |
25.5% |
n/a |
| EPS |
8.0% |
243.7% |
| DPS |
14.6% |
|
| 1 week |
10,436.29 |
+167.19 |
+1.60% |
| 1 month |
10,603.48 |
0.00 |
n/a |
| 3 months |
10,124.60 |
+478.88 |
+4.73% |
| 6 months |
9,509.40 |
+1,094.08 |
+11.51% |
| 1 year |
7,679.48 |
+2,924.00 |
+38.08% |
| SSE | 08-Apr-26 |
Transfer From |
Barry O'Regan |
0.000p | 9 |
£0.00 |
| SSE | 08-Apr-26 |
Buy |
Barry O'Regan |
3,202.83p | 9 |
£288.25 |
| BA. | 08-Apr-26 |
Exercise of option |
Brad Greve |
0.000p | 180,953 |
£0.00 |
| BP. |
580.50p |
+3.2% |
| UU. |
1,396.00p |
+2.3% |
| GSK |
2,167.00p |
+2.0% |
| HSX |
1,607.00p |
+2.0% |
| SSE |
2,757.50p |
+1.9% |
| SVT |
3,252.00p |
+1.9% |
| DCC |
5,070.00p |
+1.8% |
| JD. |
74.54p |
+1.5% |
| NG. |
1,350.60p |
+1.4% |
| SHEL |
3,448.50p |
+1.4% |
| ENT |
535.20p |
-8.4% |
| FLTR |
7,676.00p |
-5.5% |
| INF |
774.40p |
-3.8% |
| CPG |
$28.09 |
-3.6% |
| SDLF |
707.40p |
-3.5% |
| EXPN |
2,590.50p |
-3.3% |
| PSH |
4,080.00p |
-3.2% |
| CRDA |
2,907.00p |
-3.1% |
| RKT |
5,180.00p |
-3.1% |
| ANTO |
3,677.00p |
-2.6% |
Top of Page
You are here:
research